We observed that decreased expression of DACH1 in TNBC breast cancer patients was associated with poor overall survival and progression free survival and that inhibition of DACH1 significantly increased acquisition of a stem-like ALDHhiCD44+ phenotype in TNBC cells. Here, DACH1 is linked to breast cancer.